ALLIANCE PHARMA PLC

Board/Management Information • Dec 30, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5687W

Alliance Pharma PLC

30 December 2013

	30 December 2013

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Directorate Change

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that Paul Ranson has informed the Company he intends to retire from his position as Non-Executive Director of the Company during 2014.

Michael Gatenby, Alliance Pharma's Chairman, said: "I would like to thank Paul for his contribution to Alliance over the past 10 years.  I wish him every success in the future."

For further information:

### Alliance Pharma plc	### + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
### Buchanan	### + 44 (0) 20 7466 5000
Mark Court / Fiona Henson / Sophie Cowles
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Oliver Cardigan
Corporate Broking: David Poutney

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOADMMFZFGKGFZM